Join the Sirolimus group to help and get support from people like you.
Sirolimus News
FDA Approves Hyftor (sirolimus topical gel) for Facial Angiofibroma Associated with Tuberous Sclerosis
BETHESDA, Md., April 4, 2022 /PRNewswire/ – Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, and a subsidiary of Nobelpharma Co., Ltd. in...
FDA Approves Rapamune (sirolimus) for Rare Lung Disease Lymphangioleiomyomatosis
May 28, 2015 – The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of...